Followers

September 05, 2023

FDA grants tentative approval for Viatris’s new drug application to treat HIV-1 infection in paediatric patients

The fixed-dose combination of abacavir 60 mg/dolutegravir 5 mg/lamivudine 30 mg tablets for oral suspension is indicated for the treatment of HIV-1 infection in paediatric patients weighing at least six kg.


No comments:

Post a Comment